Transforming US drug access and production: MFN pricing deals and historic manufacturing investments
In November 2025, US President Donald Trump announced transformative actions to lower prescription drug costs and secure the ...
Topline data from the phase 3 ATTAIN-MAINTAIN trial evaluated orforglipron for weight maintenance after initial treatment with Wegovy or Zepbound in adults with obesity or overweight.
Morning Overview on MSN
Scientists found a hidden appetite control switch in the brain
Scientists are closing in on the brain’s internal circuitry for hunger, revealing a surprisingly precise “off switch” that ...
The perception of GLP-1s — and the people who use them — is getting better, but work still must be done to avoid stigma.
Amazon S3 on MSN
WHO supports weight loss drugs for tackling obesity crisis
Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback